1. Home
  2. CLSD

CLSD

Clearside Biomedical Inc.

Logo Clearside Biomedical Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-15-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

Founded: 2011 Country:
United States
United States
Employees: N/A City: ALPHARETTA
Market Cap: 93.4M IPO Year: 2016
Target Price: $5.00 AVG Volume (30 days): 362.5K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.53 EPS Growth: N/A
52 Week Low/High: $0.65 - $2.12 Next Earning Date: 05-09-2024
Revenue: $8,226,000 Revenue Growth: 519.89%
Revenue Growth (this year): -70.71% Revenue Growth (next year): 227.98%

Share on Social Networks: